Definium Therapeutics (DFTX) Stock Forecast & Price Target

DFTX$32.08-0.92 -2.79%
BiotechnologyGrowth Stock
Compare
Market cap$4.39BEnterprise value$4.43BRevenue (TTM)$0Market position—

Score

70
Bullish
Value
58
Quality
51
Growth
100

Definium Therapeutics, Inc. price target

DFTX
Low$52.00
Average$67.45
High$79.00
Upside vs current price+110.3%

The average target of $67.45 is +110.3% versus the current DFTX price of $32.08.

Definium Therapeutics, Inc. analyst ratings

RatingAnalysts
Strong buy5
Buy14
Hold0
Sell0
Strong sell0
ConsensusBuy

19 analysts cover DFTX.

Definium Therapeutics, Inc. EPS and revenue estimates

The estimate table for the Definium Therapeutics, Inc. keeps 2026 EPS $-3.02, 2027 EPS $-1.99, and years with fewer than three analysts are not filled in.

Fiscal yearEPS estimateRevenue estimate
2026$-3.02—
2027$-1.99$29.35M

Is Definium Therapeutics, Inc. a buy or sell?

Of the 19 analysts covering Definium Therapeutics, Inc., 19 rate it a buy (5 strong buy and 14 buy), 0 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The DFTX consensus label is Buy, beside 19 buy-side ratings and 0 sell-side ratings.

The average target of $67.45 implies +110.3% versus the current price of $32.08.

the Definium Therapeutics, Inc. closes with 19 buy-side ratings and 0 on the sell side. The headcount is Buy.

Reading the Definium Therapeutics, Inc. forecast

Analysts are far apart on DFTX. The published low is $52.00, the average is $67.45, and the high is $79.00.

From today's $32.08 print, the DFTX average target is +110.3% away.

Most of the DFTX coverage agrees: 19 of 19 analysts are on the buy side, 0 are at hold, and 0 are on the sell side, and the published consensus is Buy.

Earnings estimates for DFTX are rising: 2026 $-3.02, then 2027 $-1.99.

Coverage of DFTX is broad at 19 analysts, and the average is a crowd rather than a single desk.

Definium Therapeutics, Inc. forecast questions

What is the DFTX price target?

The published range for DFTX is $52.00 to $79.00, with an average of $67.45. That average is +110.3% versus the current price of $32.08.

Is Definium Therapeutics, Inc. a buy or sell?

Of the 19 analysts covering Definium Therapeutics, Inc., 19 rate it a buy, 0 rate it a hold, and 0 rate it a sell. The consensus is Buy, which for DFTX is 19 on the buy side, 0 at hold, and 0 on the sell side.

What is the EPS estimate for Definium Therapeutics, Inc.?

Analyst EPS estimates for Definium Therapeutics, Inc.: 2026 $-3.02, 2027 $-1.99.

What is the revenue estimate for Definium Therapeutics, Inc.?

Analyst revenue estimates for Definium Therapeutics, Inc.: 2027 $29.35M.

How many analysts cover DFTX?

19 analysts cover DFTX. Their consensus on DFTX is Buy, across those 19.

DFTX price $32.08 -0.92 -2.79%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener